BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34013840)

  • 1. Formulation development, optimization, and in vitro assessment of thermoresponsive ophthalmic pluronic F127-chitosan
    Modi D; Mohammad ; Warsi MH; Garg V; Bhatia M; Kesharwani P; Jain GK
    J Biomater Sci Polym Ed; 2021 Sep; 32(13):1678-1702. PubMed ID: 34013840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
    M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
    Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system.
    Gupta H; Jain S; Mathur R; Mishra P; Mishra AK; Velpandian T
    Drug Deliv; 2007 Nov; 14(8):507-15. PubMed ID: 18027180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system.
    Ma WD; Xu H; Wang C; Nie SF; Pan WS
    Int J Pharm; 2008 Feb; 350(1-2):247-56. PubMed ID: 17961940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery.
    Al Khateb K; Ozhmukhametova EK; Mussin MN; Seilkhanov SK; Rakhypbekov TK; Lau WM; Khutoryanskiy VV
    Int J Pharm; 2016 Apr; 502(1-2):70-9. PubMed ID: 26899977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels.
    Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S
    Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
    Pandey P; Cabot PJ; Wallwork B; Panizza BJ; Parekh HS
    Eur J Pharm Sci; 2017 Jan; 96():499-507. PubMed ID: 27771516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles.
    Lou J; Hu W; Tian R; Zhang H; Jia Y; Zhang J; Zhang L
    Int J Nanomedicine; 2014; 9():2517-25. PubMed ID: 24904211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid thermosensitive-mucoadhesive
    Fathalla Z; Mustafa WW; Abdelkader H; Moharram H; Sabry AM; Alany RG
    Drug Deliv; 2022 Dec; 29(1):374-385. PubMed ID: 35068268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical optimization of voriconazole nanoparticles loaded carboxymethyl chitosan-poloxamer based in situ gel for ocular delivery: In vitro, ex vivo, and toxicity assessment.
    Pardeshi SR; More MP; Patil PB; Mujumdar A; Naik JB
    Drug Deliv Transl Res; 2022 Dec; 12(12):3063-3082. PubMed ID: 35525868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
    Khan S; Warade S; Singhavi DJ
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies.
    Wei G; Xu H; Ding PT; Li SM; Zheng JM
    J Control Release; 2002 Sep; 83(1):65-74. PubMed ID: 12220839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
    Ma WD; Xu H; Nie SF; Pan WS
    Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of doxycycline niosomal thermoresponsive in situ gel for ophthalmic delivery.
    Gugleva V; Titeva S; Ermenlieva N; Tsibranska S; Tcholakova S; Rangelov S; Momekova D
    Int J Pharm; 2020 Dec; 591():120010. PubMed ID: 33132152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
    Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
    Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate].
    Li XY; Zhu ZJ; Cheng AY
    Yao Xue Xue Bao; 2008 Feb; 43(2):208-13. PubMed ID: 18507351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.
    Rarokar NR; Saoji SD; Raut NA; Taksande JB; Khedekar PB; Dave VS
    AAPS PharmSciTech; 2016 Apr; 17(2):436-45. PubMed ID: 26208439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation.
    Lihong W; Xin C; Yongxue G; Yiying B; Gang C
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1402-10. PubMed ID: 23944837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.